Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 198

The DOI matches its Crossref record.

Novel coronavirus infection and pregnancy

Open access
Yang, H., Wang, C., Poon, L. C. · 2020 · Ultrasound in Obstetrics & Gynecology

Abstract

The novel coronavirus infection (COVID-19) is a global public health emergency. Since the first case of COVID-19 pneumonia was reported in Wuhan, Hubei Province, China, in December 2019, the infection has spread rapidly to the rest of China and beyond. As of 1st March 2020, a total of 85 406 confirmed cases of COVID-19 infection have been reported, together with 39 597 recovered and discharged patients and 2933 deaths1. Huang et al.2 first reported a cohort of 41 patients with laboratory-confirmed COVID-19 pneumonia. They described the epidemiological, clinical, laboratory and radiological characteristics, as well as treatment and clinical outcome of the patients. Subsequent studies with larger sample sizes have shown similar findings3, 4. The diagnosis of COVID-19 pneumonia is based on epidemiological exposure, clinical manifestation, laboratory results, findings on computed tomography (CT) of the chest and a positive COVID-19 test result based on quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis of specimens acquired from the respiratory tract. However, the fifth edition of the 'New coronavirus pneumonia prevention and control program' guideline5 has stated that, in the worst-hit areas in China (Hubei Province), suspected cases with typical chest CT findings may be diagnosed clinically with COVID-19 pneumonia, as the qRT-PCR test has a false-negative rate of at least 30%. Thus, in our opinion, in the worst-hit areas, in addition to using nucleic acid tests as the gold standard for diagnosis of COVID-19 pneumonia, a combination of laboratory results, chest CT findings and a comprehensive evaluation of the patient's medical history, epidemiological exposure and symptoms is of great importance. Pregnancy is a physiological state that predisposes women to viral infection. Over and above the impact of COVID-19 infection on a pregnant woman, there are concerns relating to the potential effect on fetal and neonatal outcome; therefore, pregnant women constitute a group that requires special attention in relation to prevention, diagnosis and management. In this Opinion, we review the clinical manifestation, neonatal outcome and risk of vertical transmission of COVID-19 infection during pregnancy. Due to the physiological changes in their immune and cardiopulmonary systems, pregnant women are more likely to develop severe illness after infection with respiratory viruses. In 2009, pregnant women accounted for 1% of patients infected with influenza A subtype H1N1 virus, but they accounted for 5% of all H1N1-related deaths6. In addition, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), two notable strains of the coronavirus family, are both known to be responsible for severe complications during pregnancy, including the need for endotracheal intubation, admission to an intensive care unit (ICU), renal failure and death7, 8. Interestingly, the impact of COVID-19 infection on pregnant women appears to be less severe. Chen et al.9 reported the clinical characteristics of nine pregnant women with laboratory-confirmed COVID-19 in the third trimester, which comprised mainly fever and cough. Other symptoms included myalgia, malaise, sore throat, diarrhea and shortness of breath. Data from laboratory tests showed that the majority of patients had lymphopenia and increased C-reactive protein, and chest CT scans showed multiple patchy ground-glass shadows in the lungs. Pregnancy complications that appeared after the onset of COVID-19 infection included fetal distress in two of nine patients and premature rupture of the membranes in two of nine patients. None of the patients developed severe COVID-19 pneumonia or died. Another series10 of nine pregnant women with COVID-19 pneumonia presenting from mid-trimester onwards, or during the postpartum period, reported similar findings except for one woman requiring ICU care and ventilation for acute respiratory distress syndrome after the infection was diagnosed 2 days postpartum. In general, both studies reported that the clinical characteristics of the pregnant women with COVID-19 pneumonia were similar to those of non-pregnant adult patients who developed COVID-19 pneumonia2-4. These observations are also in line with what has been learned about COVID-19 pneumonia in pregnancy in several other hospitals in Wuhan, China. Pregnant healthcare professionals should follow risk-assessment and infection-control guidelines following exposure to patients with suspected or confirmed COVID-19. Adherence to recommended infection prevention and control practices is an important part of protecting all healthcare professionals in clinical settings11. Of major concern is whether the virus can be transmitted from mother to baby. In the study by Chen et al.9, of nine pregnant women with COVID-19 in the third trimester, no fetal death, neonatal death or neonatal asphyxia was observed9. Although four neon

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/uog.22006

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 198

Metadata

Authors
Yang, H., Wang, C., & Poon, L. C.
Venue
Ultrasound in Obstetrics & Gynecology
Publisher
Wiley
Published
2020-03-05
Volume
55
Issue
4
Pages
435-437
ISSN
  • 0960-7692 (ISSN-L)
  • 1469-0705
OpenAlex
W3010292698
Cited by
198
References
0
FWCI
24.80
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel coronavirus infection and pregnancy. https://app.cochat.ai/papers/10.1002/uog.22006
The paper
Yang, H., Wang, C., & Poon, L. C. (2020). Novel coronavirus infection and pregnancy. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.22006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.